5% stakes
Deep Track Capital
Institution
- 5% stake reports
- 92
- 5% stake stocks
- 48
- Latest report
- 26/09/02
5% stake reports
| Stock | ||
|---|---|---|
| Jatt III Acquisition JTTT09/02 | 5.83%450,000 sh | First report |
| Nurix Therapeutics NRIX08/14 | 7.45%7,736,455 sh | +1.3pp |
| X4 Pharmaceuticals XFOR08/14 | 8.33%8,040,894 sh | −1.7pp |
| Viridian Therapeutics, Inc.\DE VRDN08/14 | 3.25%3,592,740 sh | −2.0pp |
| Personalis PSNL08/14 | 3.82%4,000,000 sh | −1.7pp |
| MoonLake Immunotherapeutics MLTX08/14 | 9.74%7,999,025 sh | +3.3pp |
| MBX Biosciences MBX08/14 | 3.64%1,732,569 sh | −2.9pp |
| Immunovant IMVT08/14 | 4.55%9,341,151 sh | −1.0pp |
| Enanta Pharmaceuticals ENTA08/14 | 4.97%1,444,167 sh | −1.8pp |
| enGene Therapeutics ENGN08/14 | 0%0 sh | −6.7pp |
| Avalo Therapeutics AVTX08/14 | 6.87%3,610,000 sh | +1.1pp |
| Latigo Biotherapeutics LTGO08/13 | 7.03%4,446,656 sh | First report |
| Attovia Therapeutics ATTO08/12 | 7.45%3,207,138 sh | First report |
| Obsidian Therapeutics OBX08/11 | 5.37%3,315,605 sh | First report |
| Shattuck Labs STTK06/17 | 5.17%5,000,033 sh | First report |
| Avalo Therapeutics AVTX05/29 | 5.81%3,055,027 sh | +5.8pp |
| Definium Therapeutics DFTX05/15 | 3.01%3,000,000 sh | −2.5pp |
| Tarsus Pharmaceuticals TARS05/15 | 8.46%3,600,000 sh | +1.4pp |
| Ocular Therapeutix OCUL05/15 | 9.53%20,850,000 sh | +4.4pp |
| Nurix Therapeutics NRIX05/15 | 6.17%6,345,244 sh | −1.0pp |
